Correlation Between Enliven Therapeutics and Aligos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Aligos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Aligos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Aligos Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Aligos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Aligos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Aligos Therapeutics.
Diversification Opportunities for Enliven Therapeutics and Aligos Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Aligos is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Aligos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aligos Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Aligos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aligos Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Aligos Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Aligos Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 4.29 times less return on investment than Aligos Therapeutics. But when comparing it to its historical volatility, Enliven Therapeutics is 2.85 times less risky than Aligos Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Aligos Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,500 in Aligos Therapeutics on September 3, 2024 and sell it today you would earn a total of 1,072 from holding Aligos Therapeutics or generate 71.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Aligos Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| Aligos Therapeutics |
Enliven Therapeutics and Aligos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Aligos Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and Aligos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Aligos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aligos Therapeutics will offset losses from the drop in Aligos Therapeutics' long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Aligos Therapeutics vs. CytomX Therapeutics | Aligos Therapeutics vs. Spero Therapeutics | Aligos Therapeutics vs. Instil Bio | Aligos Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |